Bladder Cancer

BLADDER CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

The Vital Role Genetic Testing Plays in Bladder Cancer Treatments

Recent research suggests cancer patients who have undergone genetic testing for inherited or acquired mutations were more likely to have prolonged overall survival than patients who did not,
FDA Label Restriction Triggers Increased Uptake of PD-L1 Assays in Urothelial Carcinoma

FDA label changes for certain immunotherapies may have prompted a marked increase in the use of PD-L1 assays.
Thawing Frozen Cancer Drug Labels

As medical care rapidly evolves, there’s really no debate over the potential for drug labels to become outdated, particularly in the high stakes world of cancer treatment. The question is how best to ameliorate the problem, while still protecting the process from financial and other conflicts. Off-label prescribing of cancer drugs is common, occurring 30%…
Adding Gemcitabine at the Time of Resection Reduces Recurrence, Cost in Early-Stage Bladder Cancer

Though early-stage bladder cancer is infrequently fatal, the decrease in recurrence rates has a meaningful impact on the quality of life for patients as well as treatment costs.
Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.

VIDEO SERIES

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Bladder-sparing Strategies

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

AUA Guidelines: Non-muscle Invasive Bladder Cancer

Bladder Cancer Biomarkers: New and Old

Current Research and New Treatments

PD-L1 Inhibitors Changing the Standard of Care

The Emergence of Personalized Medicine

BLADDER CANCER NEWS

mri, bladder cancer, mri scan, bladder scan, urology, nephrology, aua 2017

MRI Useful for Diagnosing Muscle-Invasive Bladder Cancer

August 6, 2020

Glasgow Prognostic Score Predicts Adverse Pathology, Survival in UTUC

August 5, 2020

FDA_drug approval

Bavencio Approved for First-Line Urothelial Carcinoma Maintenance Treatment

July 2, 2020

Lymph node in a man

Study: Template-Based LND May Aid Local UTUC Control

June 18, 2020

Avelumab Shown to Prolong Survival in Advanced Urothelial Carcinoma

May 31, 2020

Next post in Bladder Cancer

Glasgow Prognostic Score Predicts Adverse Pathology, Survival in UTUC